INTESTINAL BACTERIA BUTYRIBACTERINTESTINI AND APPLICATION THEREOF
- 专利权人:
- BGI Shenzhen
- 发明人:
- Qiang Feng,Wenbin Xue,Yuanqiang Zou,Xiaoping Li,Chuan Liu,Xin Li
- 申请号：
- US15755926
- 公开号：
- US20180339034A1
- 申请日:
- 2016.03.21
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- The use of a combination of oxycodone and naloxone in the treatment of pain in patients with pain, and at least an additional disease chosen between diseases that cause intestinal dislocation or increase the risk of intestinal bacterial transmission.". PCT
- A COMBINATION OF OXYCODONE AND NALOXONE FOR USE IN TREATING PAIN IN PATIENTS SUFFERING FROM PAIN AND A DISEASE RESULTING IN INTESTINAL DYSBIOSIS AND/OR INCREASING THE RISK FOR INTESTINAL BACTERIAL TRANSLOCATION
- Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
- A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
- A COMBINATION OF OXYCODONE AND NALOXONE FOR USE IN TREATING PAIN IN PATIENTS SUFFERING FROM PAIN AND A DISEASE RESULTING IN INTESTINAL DYSBIOSIS AND/OR INCREASING THE RISK FOR INTESTINAL BACTERIAL TRANSLOCATION
